CG
PFE icon

Clarus Group’s Pfizer PFE Stock Holding History

Clarus Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,757
Closed -$206K – 105
2024
Q4 		$206K Sell
7,757
-473
-6% -$12.8K 0.07% 100
2024
Q3 		$238K Sell
8,230
-84
-1% -$2.45K 0.1% 98
2024
Q2 		$233K Sell
8,314
-10,274
-55% -$283K 0.1% 104
2024
Q1 		$516K Buy
18,588
+426
+2% +$11.8K 0.36% 48
2023
Q4 		$523K Sell
18,162
-78
-0.4% -$2.36K 0.4% 47
2023
Q3 		$605K Sell
18,240
-526
-3% -$18.6K 0.44% 43
2023
Q2 		$688K Buy
18,766
+1,641
+10% +$63.9K 0.5% 32
2023
Q1 		$699K Buy
17,125
+15
+0.1% +$648 0.66% 25
2022
Q4 		$877K Buy
17,110
+12
+0.1% +$575 0.77% 23
2022
Q3 		$748K Sell
17,098
-287
-2% -$13.9K 0.68% 30
2022
Q2 		$911K Sell
17,385
-288
-2% -$14.7K 0.76% 24
2022
Q1 		$915K Sell
17,673
-5,580
-24% -$290K 0.62% 26
2021
Q4 		$1.25M Hold
23,253
– – 0.84% 21
2021
Q3 		$1M Buy
23,253
+13
+0.1% +$576 0.69% 25
2021
Q2 		$921K Sell
23,240
-1,190
-5% -$46.3K 0.69% 25
2021
Q1 		$877K Buy
24,430
+17
+0.1% +$604 0.73% 25
2020
Q4 		$848K Buy
+24,413
New +$895K 0.73% 22

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Clarus Group's PFE Position: Q1 2025 in Review

Clarus Group sold out of Pfizer (PFE) in Q1 2025, closing a stake of 7,757 shares — an estimated $206K sold.

Clarus Group first reported a position in PFE in Q4 2020 and held it in 17 quarters. The position peaked at $1.25M in Q4 2021. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Clarus Group reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Clarus Group sold 7,757 Pfizer shares in Q1 2025, an estimated $206K.
  • Clarus Group first reported a position in Pfizer in Q4 2020 and held it in 17 quarters.
  • Clarus Group's Pfizer position peaked at $1.25M in Q4 2021.
  • 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Clarus Group's 13F filing for Q1 2025, filed 25 Apr 2025.